Table 2. ADME Prediction of Oxadiazole Analogues (6a–j).

s. no.	compound	% ABS	volume	TPSA	NROTB	HBA	HBD	Log P (iLOGP)	MW	BBB permeation	GI absorption	Lipinski’s violations
1	6a	91.42	232.24	50.95	3	7	1	2.73	309.22	yes	high	0
2	6b	91.42	240.85	50.95	3	6	1	2.90	325.67	no	high	0
3	6c	91.42	245.20	50.95	3	6	1	2.99	370.12	no	high	0
4	6d	91.42	243.87	50.95	3	6	1	2.88	305.25	yes	high	0
5	6e	88.24	252.86	60.18	4	7	1	2.93	321.25	yes	high	0
6	6f	91.42	240.85	50.95	3	6	1	3.01	325.67	no	high	0
7	6g	88.24	252.86	60.18	4	7	1	3.11	321.25	yes	high	0
8	6h	91.42	260.43	50.95	3	6	1	3.23	319.28	yes	high	0
9	6i	91.42	260.43	50.95	3	6	1	3.23	319.28	yes	high	0
10	6j	91.42	245.78	50.95	3	7	1	2.85	343.66	no	high	0